Picture of MD Medical Investments logo

MDMG MD Medical Investments News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMicro Cap

REG - MD Medical Group - MDMG TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS




 



RNS Number : 6527X
MD Medical Group Investments PLC
01 September 2020
 

 

MD MEDICAL GROUP TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS ON 07 SEPTEMBER

 

01 September 2020, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company"- LSE: MDMG), a leading Russian private healthcare provider, announces that it will publish its financial results under International Financial Reporting Standards ("IFRS") for the six months ended 30 June 2020 on Monday, 07 September 2020.

 

The Company will host a conference call and webcast for investors and analysts on the same day at 5.00 pm Moscow time (3.00 pm London; 10.00 am New York).

 

MD Medical Group will be represented by:

·    Dr Mark Kurtser, СEO and Member of Board of Directors

·    Mr Andrey Khoperskiy, Deputy CEO for Finance and Economics

·    Mr Dmitry Yakushkin, Head of IR Department

 

The press release, presentation and financial statements will be available prior to the conference call on the Company's website: http://www.mcclinics.com

 

Skype link to the Conference call:

 

https://meet.mcclinics.ru/r.beschastnyy/5PDKC8JP

 

Join by phone

+ 7-909-530-02-24 (Russia)

 

Conference ID: 65783

 

The conference call will be recorded and available for replay at the Company's website.

 

Please note that this call is only intended for investors and analysts.

 

For further information please contact:

 

Dmitry Yakushkin

Head of IR Department

MD Medical Group Investments Plc
Tel: +7 139-87-40, ext. 16329
ir@mcclinics.ru 

 

 

 

 

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov on Don

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORSSMSAFESSEFU

Recent news on MD Medical Investments

See all news